Effect of paclitaxel pretreatment on radiation-induced p53-dependent apoptosis

Anticancer Research

Volumn 19, Issue 6 B, 1999, Pages 5101-5110

  Kawashima, Miho ^a   Hasegawa, Masatoshi ^a   Hayakawa, Kayoko ^a   Nasu, Sachiko ^a   Toda, Hisako ^a   Suzuki, Yoshiyuki ^a   Mitsuhashi, Norio ^a   Niibe, Hideo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; P53; Paclitaxel; Radiation

Indexed keywords

KI 67 ANTIGEN; PACLITAXEL; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EPENDYMOBLASTOMA; HUMAN; HUMAN TISSUE; IRRADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PACLITAXEL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033379936     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Rowinsky EK, Cazenave LA and Donehower RC: Taxol: A novel investigational antimicrotubule agent. J Natl Cancer Inst 82: 1247-1259, 1990.
2. Kirkbride P, Gelmon K, Eisenhauer E, Fisher B and Dulude H: A phase I/II study of paclitaxel (taxol) and concurrent radiotherapy in advanced nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 39: 1107-1111, 1997.
3. Safran H, King T, Choy H, Gollerkeri A, Kwakwa H, Lopez F, Cole B, Myers J, Tarpey J and Rosmarine A: p53 mutations do not predict responce to paclitaxel/ radiation for nonsmall lung carcinoma. Cancer 78: 1203-1210, 1996.
4. Au J L-S, Gan DLY, Gao X, Johnson AL, Johnston J, Millenbaugh NJ, Jang SH, Kuh H-J, Chen C-T and Wientjes MG: Pharmacodynamics of immediate and delayed effects of paclitaxel: Role of slow apoptosis and intracellar drug retention. Cancer Res 58: 2141-2148, 1998.
5. Milross CG, Mason KA, Hunter NR, Chung W-K, Peters LJ and Milas L: Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst 88: 1308-1314, 1996.
6. Debernardis D, Graniela ES, Feudis P, Vikhanskaya F, Russo P, Parodi S, D'incalci M and Broggini M: p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res 57: 870-874, 1997.
7. Hall EJ: Radiosensitivity and cell age in the mitotic cycle. Radiology for the radiologist, fourth edition. Philadelphia, Lippincott Company, 1994, pp91-105.
8. Choy H, Rodriguez FF, Koester S, Hilsenbeck S and Hoff DD: Investigation of taxol as a potential radiation sensitizer. Cancer 71: 3774-3778, 1993.
9. Ingram ML and Redpath JL: Subadditive interaction of radiation and Taxol in vitro. Int J Radiat Oncol Biol Phys 37: 1139-1144, 1997.
10. Liebmann J, Hersher L, Fisher J, Teague D and Cook JA: Antagonism of paclitaxel cytotoxicity by X-rays: Implications for the sequence of combined modality therapy. Int J Oncol 8: 991-996, 1996.
11. Hasegawa M, Mitsuhashi N, Yamakawa M, Furuta M, Maebayashi K, Imai R, Hayakawa K and Niibe H: p53 protein expression and radiation-indused apoptosis in human tumors translated to nude mice. Radiat Med 15: 171-176, 1997.
12. Kerr JFR and Winterford CM: Apoptosis. Cancer 73: 2013-2026, 1994.
13. Gavrieli Y, Sherman Y and Beb-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992.
14. Mason KA, Milas L and Peters LJ: Effect of paclitaxel (taxol) alone and in combination with radiation on the gastrointestinal mucosa. Int J Radiat Oncol Biol Phys 32: 1381-1389, 1995.
15. Jordan MA, Wendell K, Gardiner S, DerryWB, Copp H and Wilson L: Mitotic block induced in Hela cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 56: 816-825, 1996.
16. Gupta N, Hu LJ and Deen DF: Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation. Int J Radiat Oncol Biol Phys 37: 885-895, 1997.
17. Saito Y, Mitsuhashi N, Takahashi T, Sakurai H, Nozaki M, Ishikawa H, Nasu S, Hayakawa K and Niibe H: Cytotoxic effect of paclitaxel (taxol) either alone or in combination with irradiation in two rat yolk sac tumour cell lines with different radiosensitivities in vitro. Int J Radiat Biol 73: 225-231, 1998.
18. Cividalli A, Arcangeli G, Cruciani G, Livdi E, Cordelli E and Tirindelli DD: Enhancement of radiation responce by paclitaxel in mice according to different treatment schedules. Int J Radiat Oncol Biol Phys 40: 1163-1170, 1998.
19. Milross CG, Mason KA, Hunter NR, Terry NHA, Patel N, Harada S, Jibu T, Seong J and Milas L: Enhanced radioresponse of paclitaxel-sensitive and -resistant tumours in vivo. Eur J Cancer 33: 1299-1308, 1997.
20. Milas L, Saito Y, Hunter NR, Milross CG and Mason KA: Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma. Radiother Oncol 40: 163-170, 1996.
21. Milas L, Hunter NR, Mason KA, Milross CG, Saito Y and Peters LJ: Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res 55: 3564-3568, 1995.
22. Milas L, Hunter NR, Mason KA, Kurdoglu B and Peters LJ: Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res 54: 3506-3510, 1994.
23. Gorodetsky R, Levdansky L, Ringel I and Vexler A: Paclitaxel-induced modification of the effects of radiation and alterations in the cell cycle in normal and tumor mammalian cells. Radiat Res 150: 283-291, 1998.
24. Talwar N and Redpath JL: Schedule dependence of the interaction of radiation and taxol in Hela cells. Radiat Res 148: 48-53, 1997.
25. Hennequin C, Giocanti N and Favandon V: Interaction of ionizing radiation with paclitaxel (taxol) and docetaxel (taxotere) in Hela and SQ 20B cells. Cancer Res 56: 1842-1850, 1996.
26. Szczepanski LV and Trott KR: Post-irradiation proliferation kinetics of serially transplanted murine adenocarcinoma. Br J Radiol 48: 200-208, 1975.
27. Linn SC, Pinedo HM, Ark-Otte J, Hoekman K, Honkoop AH, Vermorken JB and Giaccone G: Expression of drug resistance proteins in breast cancer, in relation to chemotherapy. Int J Cancer 71: 787-795, 1997.
28. Blagosklonny MV and El-Deiry WS: Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells. Int J Cancer 75: 933-940, 1998.
29. Zaffaroni N, Silvestrini R, Bearzatto A, Gornati D and Villa R: Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and - resistant human ovarian cancer cells. Br J Cancer 77: 1378-1385, 1998.
30. Polizzi D, Pratesi G, Tortoreto M, Supino R, Riva A, Bombardelli E and Zunino F: A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts. Cancer Res 59: 1036-1040, 1999.
31. Fan S, Cherney B, Reinhold W, Rucker K and O'Connor PM: Disruption of p53 function in immortalized human cells does not affect survivals or apoptosis after taxol or vincristine treatment. Clin Cancer Res 4: 1047-1054, 1998.
32. Roth W, Wagenknecht B, Grimmel C, Dichgans J and Weller M: Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest. Br J Cancer 77: 404-411, 1998.
33. Jacks T and Weinberg RA: Cell-cycle control and its watchman. Nature 381: 643-644, 1996.
34. Strobel T, Swanson L, Korsmeyer S and Cannistra SA: Bax enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proc Natl Acad Sci 93: 14094-14099, 1996.
35. Wahl AF, Donaldson KL, Fairchild C, Lee FYF, Foster SA, Demers GW and Galloway DA: Loss of normal p53 function confers sensitization to taxol by increasing G2/M arrest and apoptosis. Nature Med 2: 72-79, 1996.
36. Lanni JS, Lowe SW, Licitra EJ, Liu JO and Jacks T: p53-independent apoptosis induced by paclitaxel through an indirect mechanism. Proc Natl Acad Sci 94: 9679-9683, 1997.
37. Saito Y, Milross CG, Hittelman WN, Li D, Jibu T, Peters LJ and Milas L: Effect of radiation and paclitaxel on p53 expression in murine tumors sensitive or resistant to apoptosis induction. Int J Radiat Oncol Biol Phys 38: 623-631, 1997.
38. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 562: 849-852, 1993.
39. Macfarlane M, Jones NA, Dive C and Cohen GM: DNA-damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes. Mol Pharmacol 50: 900-911, 1996.
40. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T: p53 is required for radiation induced apoptosis in mouse thymocytes, Nature 562: 847-849, 1993.
41. Torres K and Horwitz SB: Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res 58: 3620-3626, 1998.